SCHEMBL24815672

SCHEMBL24815672

O=C(CS(=O)(=O)c1ncccn1)N1Cc2ccccc2C1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ POLB P06746 1/20 0.43
▸ NOTUM Q6P988 1/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ LMNA P02545 1/20 0.42
▸ NAMPT P43490 4/20 0.40
▸ HTT P42858 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ HPGD P15428 1/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ TAAR1 Q96RJ0 1/20 0.39
▸ GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29987155 1.00 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2POLBNOTUMRAB9A
SCHEMBL24815671 0.85 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2POLBNOTUMRAB9A
SCHEMBL29986504 0.85 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2POLBNOTUMRAB9A
SCHEMBL29987245 0.81 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2POLBNOTUMRAB9A
SCHEMBL24816165 0.81 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2POLBNOTUMRAB9A
SCHEMBL24815673 0.80 SMN1; SMN2 (0.67) ALDH1A1SMN1; SMN2POLBNOTUMRAB9A
SCHEMBL29986910 0.80 SMN1; SMN2 (0.67) ALDH1A1SMN1; SMN2POLBNOTUMRAB9A
SCHEMBL24815706 0.79 NAMPT (0.42) ALDH1A1SMN1; SMN2POLBNOTUMRAB9A
SCHEMBL24815669 0.79 SMN1; SMN2 (0.42) ALDH1A1SMN1; SMN2POLBNOTUMRAB9A
SCHEMBL29986905 0.79 SMN1; SMN2 (0.42) ALDH1A1SMN1; SMN2POLBNOTUMRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH ALDH1A1 3533/4885SMN1; SMN2 1176/4885POLB 4115/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH ALDH1A1 3533/4885SMN1; SMN2 1176/4885POLB 4115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback